EIR OPK Biotech Nov 2002

Megan Haggerty FDA, Richard Penta FDA, Jason Rossi FDA$595.00 - Available Now

FDA investigators audited the OPK Biotech - Cambridge, MA, United States facility and issued inspectional observation (via FDA 483) on 14 Nov 2002.

Product details

  • Category:
  • Inspection end: 14 Nov 2002
  • Location: Cambridge, United States
  • FEI: 1222147
Add To Cart